Abstract
N-[7-Nitrobenz-2-oxa-1,3-diazol-4-yl]psychosine sulfate (NBDPS), a fluorescent analog of cerebroside sulfate (CS), was synthesized and tested as an alternative to the radiolabeled forms of CS used for assaying arylsulfatase A (ASA) in its physiological role as a cerebroside sulfate sulfohydrolase. NBD-PS simulates the natural substrate for ASA. Protocols have been developed for its use in differentiating low enzyme activities in diagnostic samples. Hydrolysis of NBD-PS is specific for ASA and optimal assay parameters were identical to those determined for CS. Differentiations between each of the major phenotypes for ASA activity were possible in the set of samples tested. One particular advantage was the ability to discriminate between individuals exhibiting arylsulfatase A pseudodeficiency and the truly deficient individuals with metachromatic leukodystrophy. Differential diagnosis was possible with fibroblast extracts by an assay that is more sensitive than procedures employing radioisotopes. Reaction products may be analyzed quantitatively by HPLC, or semiquantitatively with TLC. NBD-PS provides a simpler, safer, and more cost-effective means of performing natural substrate enzyme assays for ASA. Phenotyping with the fluorescence assay is an effective alternative to the laborious radioactive CS preparations and tissue culture loading studies that have previously been necessary.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bach G., Dagan A., Herz B., and Gatt S. (1987) Diagnosis of arylsulfatase A deficiency in intact cultured cells using a fluorescent derivative of cerebroside sulfate.Clin. Genet. 31, 211–217.
Baum H. and Dodgson K. S. (1958) Studies on sulphatases: The anomalous kinetics of arylsulphatase A of human tissues: Interpretation of the anomalies.Biochem. J. 69, 573–582.
Baum H., Dodgson K. S., and Spencer B. (1959) The assay of arylsulfatase A and B in human urine.Clin. Chim. Acta 4, 453–455.
Butterworth J., Broadhead D. M., and Keay A. J. (1978) Low arylsulphatase A activity in a family without metachromatic leukodystrophy.Clin. Genet. 14, 213–218.
Dinur T., Grabowski G. A., Desnick R. J., and Gatt S. (1984) Synthesis of a fluorescent derivative of glucosyl ceramide for the sensitive determination of glucocerebrosidase activity.Anal. Biochem. 136, 223–234.
Dubois G., Turpin J. C., and Baumann N. (1975) Absence of ASA activity in healthy father of a patient with metachromatic leukodystropy.N. Engl. J. Med. 293, 302.
Dubois G., Zalc B., Le Saux F., and Baumann N. (1980) Stearoyl-1-[14C] sulfogalactosyl sphingosine ([14C]-sulfatide) as substrate for cerebroside sulfatase assay.Anal Biochem. 102, 313–317.
Fluharty A. L., Davis M. L., Kihara H., and Kritchevsky G. (1974) Simplified procedure for preparation of35S-labeled brain sulfatide.Lipids 9, 865–869.
Fluharty A. L., Stevens R. L., Sanders D. L., and Kihara H. (1974) Arylsulfatase B deficiency in Maroteaux-Lamy syndrome cultured fibroblasts.Biochem. Biophys. Res. Commun. 59, 455–461.
Fluharty A. L., Stevens R. L., and Kihara H. (1978) Cerebroside sulfate hydrolysis by fibroblasts from a metachromatic leukodystrophy parent with deficient arylsulfatase A.J. Pediatr. 92, 782–784.
Fluharty A. L., Stevens R. L., Miller R. T., and Kihara H. (1980) Bile salt activation of cerebroside sulphate sulphohydrolase.Biochem. J. 189, 45–49.
Fluharty A. L., Meek W. E., and Kihara H. (1983) Pseudo arylsulfatase A deficiency: Evidence for a structurally altered enzyme.Biochem. Biophys. Res. Commun. 112, 191–197.
Folch J., Lees M., and Sloane-Stanley G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissues.J. Biol. Chem. 226, 497–509.
Geiselmann V., Polten A., Kreysing J., and von Figura K. (1989) Arylsulfatase A pseudodeficiency: Loss of a polyadenylylation signal and N-glycosylation site.Proc. Nat. Acad. Sci. (USA) 86, 9436–9440.
Herz B. and Bach G. (1984) Arylsulfatase A in pseudodeficiency.Hum. Genet. 66, 147–150.
Hohenschutz C., Eich P., Freidl W., Waheed A., Conzelmann E., and Propping P. (1989) Pseudodeficiency of arylsulfatase A: A common genetic polymorphism with possible disease implications.Hum. Genet. 82, 45–48.
Iwamori M., Moser H. W., and Kishimoto Y. (1976) Solubilization and partial purification of steroid sulfatase from rat liver: Characterization of estrone sulftase.Arch. Biochem. Biophys. 174, 199–208.
Kean E. L. (1968) Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides.J. Lipid Res. 9, 319–327.
Kihara H., Ho C. K., Fluharty A. L., Tsay K. K., and Hartlage P. L. (1980) Prenatal diagnosis of metachromatic leukodystrophy in a family with pseudo arylsulfatase A deficiency by the cerebroside sulfate loading test.Pediat. Res. 14, 224–227.
Kolodny E. H. (1989) Metachromatic leukodystrophy and multiple sulfatase deficiency: Sulfatide lipidosis, inThe Metabolic Basic of Inherited Disease (Scriver C. R., Beaudet A. L., Sly W. S., and Valle D., eds.), 6th Ed., Vol II, pp. 1721–1750, McGraw Hill, New York.
Koshy K. M. and Boggs J. M. (1982) A high yield saponification of galactosylceramide I3-sulfate.Lipids 17, 998–1000.
Kudoh T. and Wenger D. A. (1982) Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts.J. Clin. Invest. 70, 89–97.
Longmuir K. J., Martin O. C., and Pagano R. E. (1985) Synthesis of fluorescent and radiolabeled analogues of phosphatidic acid.Chem. Phys. Lipids 36, 197–207.
Louis A. I., and Fluharty A. L. (1990) Activator-dependent hydrolysis of myelin cerebroside sulfate by arylsulfatase A.Dev. Neurosci. in press.
Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent.J. Biol. Chem. 193, 265–275.
Marchesini S., Viani P., Cestaro B., and Gatt S. (1989) Synthesis of pyrene derivatives of cerebroside sulfate and their use for determining arylsulfatase A activity.Biochim. Biophys. Acta 1002, 14–19.
O’Brien J. S. (1989) β-Galactosidase deficiency (GM1 gangliosidosis, galactosialidosis, and Morquio syndrome type B); Ganglioside sialidase deficiency (mucolipidosis IV), inThe Metabolic Basis of Inherited Disease (Scriver C. R., Beaudet A. L., Sly W. S., and Valle D., eds.), 6th Ed., Vol II, pp. 1797–1806, McGraw Hill, New York.
Porter M. T., Fluharty A. L., Trammell J., and Kihara H. (1971) A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy.Biochem. Biophys. Res. Commun. 44, 660–666.
Raghaven S. S., Gajewski A., and Kolodny E. H. (1981) Leukocyte sulfatidase for the reliable diagnosis of metachromatic leukodystrophy.J. Neurochem. 36, 724–731.
Sarafian T. A., Fluharty A. L., Kihara H., Helfand G., and Edmond J. (1982) Large-scale purification of pyrogen-free human arylsulfatase A.J. Appl. Biochem. 4, 126–132.
Suzuki K. and Suzuki Y. (1989) Galactosylceramide lipidosis: Globoid cell leukodystrophy (Krabbe disease), inThe Metabolic Basis for Inherited Disease (Scriver C. R., Baudet A. L., Sly W. S., and Valle D., eds.), 6th Ed., Vol. II, pp. 1699–1720, McGraw Hill, New York.
Wenger D. A., Sattler M., Clark C., and McElvey H. (1974) An improved method for the identification of patients and carriers of Krabbe’s disease.Clin. Chim. Acta 56, 199–206.
Zeigler M., Zlotogora J., Regev R., Dagan A., Gatt S., and Bach G. (1984) Prenatal diagnosis of Krabbe disease using a fluorescent derivative of galactosylceramide.Clin. Chim. Acta 142, 313–318.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Louis, A.I., Widen, K.E., Tsay, K.K. et al. Synthesis and characterization of NBD-PS: A fluorescent analog of cerebroside sulfate for diagnosis of arylsulfatase a deficiency disorders. Molecular and Chemical Neuropathology 14, 113–130 (1991). https://doi.org/10.1007/BF03159931
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03159931